Laboratory Question for the Week of April 22, 2024
What do the category III codes for digital pathology represent in 2023 and are there any new additional codes effective in 2024?
Mounting complexity, confusing new rules, new technologies, and diminishing reimbursements could place laboratory coding and compliance into peril, with lost revenue on the table and potential risk for audits. If you’re involved with coding and billing for molecular pathology, molecular biology, cytogenics or drug-of-abuse testing, you know exactly what we’re talking about! How can you possibly keep up with the continual advances?
Count on the laboratory resources from MedLearn Publishing to ensure compliant coding and billing. You’ll get guidance from leading lab authorities, presented in easy-to-understand terms.
Print Format
Searchable eBook Format
What do the category III codes for digital pathology represent in 2023 and are there any new additional codes effective in 2024?
When both an adequacy assessment and a definitive diagnosis are rendered during a cytopathology evaluation, which codes should be reported?
For 2024, which code is associated with assessing the balance of estrogen and progesterone in the vaginal squamous epithelium?
What considerations should healthcare providers keep in mind regarding the medical necessity criteria when deciding whether to separately bill or bundle codes 88740 and 88741 for transcutaneous procedures?
Equip yourself and your team with actionable solutions to conquer laboratory coding challenges, optimize revenue, and ensure compliance. Join us as we dive into the practical application of the many 2024 code changes and empower you to achieve coding excellence.
A pioneer in the development of MedLearn Publishing’s laboratory product line explains why she believes these resources have been so popular for the past two decades.
Happy World Health Day! Our exclusive webcast, ‘2024 SDoH Update: Navigating Coding and Screening Assessment,’ is just $99 for a limited time! Use code WorldHealth24 at checkout.